SOX2 and lung carcinoma: Lung cancer stem-like cells exhibited higher SLC7A11 expression that did lung cancer cells, and the stem cell transcription factor SOX2 activated SLC7A11, thus enhancing the resistance of lung cancer stem-like cells to ferroptosis [66].